
NGVT
Ingevity Corp
- Overview
- Forecast
- Valuation
- Earnings
High
46.240
Open
46.240
VWAP
--
Vol
186.70K
Mkt Cap
1.66B
Low
45.410
Amount
--
EV/EBITDA(TTM)
7.82
Total Shares
36.33M
EV
3.01B
EV/OCF(TTM)
18.14
P/S(TTM)
1.25
Ingevity Corporation is engaged in developing, marketing, and bringing to market solutions that are renewably sourced. The Company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Performance Materials segment engineers, manufactures, and sells hardwood-based, chemically activated carbon products, which are produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Performance Chemicals segment is comprised of two product lines: road technologies and industrial specialties. Its products are utilized in pavement construction, preservation, reconstruction and recycling, agrochemical dispersants, paper chemicals and other diverse industrial uses. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
378.70M
-3.05%
1.163
+15.1%
372.00M
-1.3%
1.305
+18.64%
290.67M
-2.72%
0.800
-15.79%
Estimates Revision
The market is revising Downward the revenue expectations for Ingevity Corporation (NGVT) for FY2025, with the revenue forecasts being adjusted by -1.9% over the past three months. During the same period, the stock price has changed by 38.24%.
Revenue Estimates for FY2025
Revise Downward

-1.9%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-3.46%
In Past 3 Month
Stock Price
Go Up

+38.24%
In Past 3 Month
3 Analyst Rating

10.23% Upside
Wall Street analysts forecast NGVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NGVT is 50.33 USD with a low forecast of 47.00 USD and a high forecast of 56.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy

10.23% Upside
Current: 45.660

Low
47.00
Averages
50.33
High
56.00

10.23% Upside
Current: 45.660

Low
47.00
Averages
50.33
High
56.00
Wells Fargo
Michael Sison
Hold
Maintains
$45 → $32
2025-04-09
Reason
Wells Fargo
Michael Sison
Price Target
$45 → $32
2025-04-09
Maintains
Hold
Reason
Wells Fargo lowered the firm's price target on Ingevity to $32 from $45 and keeps an Equal Weight rating on the shares. Given increased risks in a post tariff world, the firm recommends a more defensive position within the chemicals sector into Q1 2025 results as Wells expects cautious outlook commentary.
BMO Capital
John McNulty
Hold
to
Buy
Upgrades
$62 → $65
2025-02-26
Reason
BMO Capital
John McNulty
Price Target
$62 → $65
2025-02-26
Upgrades
Hold
to
Buy
Reason
BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $61 and keeps a Market Perform rating on the shares after its Q4 earnings beat. The company is starting to reap the benefits of roughly two years of work to escape the pressures of its CTO - Crude Tall Oil - platform, the analyst tells investors in a research note. Ingevity is also seeing its high value add Performance Materials business enjoying growth despite muted end-market volumes, BMO adds.
BMO Capital
John McNulty
Hold
Maintains
$61 → $62
2025-02-20
Reason
BMO Capital
John McNulty
Price Target
$61 → $62
2025-02-20
Maintains
Hold
Reason
BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $61 and keeps a Market Perform rating on the shares after its Q4 earnings beat. The company is starting to reap the benefits of roughly two years of work to escape the pressures of its CTO - Crude Tall Oil - platform, the analyst tells investors in a research note. Ingevity is also seeing its high value add Performance Materials business enjoying growth despite muted end-market volumes, BMO adds.
BMO Capital
John McNulty
Hold
Maintains
$40 → $47
2024-10-31
Reason
BMO Capital
John McNulty
Price Target
$40 → $47
2024-10-31
Maintains
Hold
Reason
BMO Capital
John McNulty
Hold
Maintains
$42 → $40
2024-09-30
Reason
BMO Capital
John McNulty
Price Target
$42 → $40
2024-09-30
Maintains
Hold
Reason
BMO Capital lowered the firm's price target on Ingevity to $40 from $42 and keeps a Market Perform rating on the shares as part of a broader research note on U.S. Chemicals. The firm's channel checks point to a handful of end-markets and commodities that enjoyed relative strength, while at the same time there were pockets of incremental weakness, particularly in Europe and China, the analyst tells investors in a research note. For the company, BMO is lowering its Performance Chemicals segment outlook for the second half of the year as weather has been an issue for Ingevity so far this summer, which impacts the paving business.
BMO Capital
John McNulty
Hold
Maintains
$45 → $42
2024-08-05
Reason
BMO Capital
John McNulty
Price Target
$45 → $42
2024-08-05
Maintains
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Ingevity Corp (NGVT.N) is 11.34, compared to its 5-year average forward P/E of 13.28. For a more detailed relative valuation and DCF analysis to assess Ingevity Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
13.28
Current PE
11.34
Overvalued PE
16.54
Undervalued PE
10.01
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
8.71
Current EV/EBITDA
7.93
Overvalued EV/EBITDA
9.88
Undervalued EV/EBITDA
7.55
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
1.54
Current PS
1.27
Overvalued PS
2.03
Undervalued PS
1.05
Financials
Annual
Quarterly
FY2025Q1
YoY :
-16.50%
284.00M
Total Revenue
FY2025Q1
YoY :
+40.69%
65.00M
Operating Profit
FY2025Q1
YoY :
-136.61%
20.50M
Net Income after Tax
FY2025Q1
YoY :
-136.36%
0.56
EPS - Diluted
FY2025Q1
YoY :
-153.66%
15.40M
Free Cash Flow
FY2025Q1
YoY :
+36.23%
39.93
Gross Profit Margin - %
FY2025Q1
YoY :
+33.08%
7.04
FCF Margin - %
FY2025Q1
YoY :
-143.84%
7.22
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
107.0K
Volume
Months
6-9
1
429.8K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NGVT News & Events
Events Timeline
2025-05-05 (ET)
2025-05-05
16:22:38
Ingevity sees FY25 revenue $1.25B-$1.4B, consensus $1.36B

2025-05-05
16:22:04
Ingevity reports Q1 adjusted EPS 99c, consensus 74c

2025-03-10 (ET)
2025-03-10
16:17:25
Ingevity names David Li president, CEO

Sign Up For More Events
Sign Up For More Events
News
2.0
07-22NewsfilterIngevity named one of America's Best Mid-sized Companies by TIME
6.5
07-17NASDAQ.COMAnalysts See 15% Gains Ahead For The Holdings of VB
3.5
07-07NewsfilterIngevity releases 2024 sustainability report, highlights product innovation and technologies for a sustainable future
Sign Up For More News
People Also Watch

WTTR
Select Water Solutions Inc
9.780
USD
+0.51%

KOS
Kosmos Energy Ltd
2.390
USD
+7.66%

NTB
Bank of NT Butterfield & Son Ltd
44.470
USD
+0.23%

FCF
First Commonwealth Financial Corp
16.310
USD
+0.25%

SONO
Sonos Inc
11.440
USD
+1.69%

BBUC
Brookfield Business Corp
32.030
USD
-0.16%

UNFI
United Natural Foods Inc
28.430
USD
+0.78%

NWBI
Northwest Bancshares Inc
12.680
USD
+0.40%

GTY
Getty Realty Corp
27.560
USD
-0.76%

KRP
Kimbell Royalty Partners LP
14.960
USD
+1.77%
FAQ

What is Ingevity Corp (NGVT) stock price today?
The current price of NGVT is 45.66 USD — it has decreased -1.59 % in the last trading day.

What is Ingevity Corp (NGVT)'s business?

What is the price predicton of NGVT Stock?

What is Ingevity Corp (NGVT)'s revenue for the last quarter?

What is Ingevity Corp (NGVT)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Ingevity Corp (NGVT)'s fundamentals?

How many employees does Ingevity Corp (NGVT). have?
